−1.19CAD
−30.721MCAD
80.021MCAD
30.082M
About HLS THERAPEUTICS INC
Sector
CEO
Craig Millian
Headquarters
Etobicoke
Website
Employees (FY)
99
Founded
2014
ISIN
CA40390B1094
HLS Therapeutics, Inc. operates as a pharmaceutical company. It focuses on clinically differentiated pharmaceutical products in the specialty central nervous system (CNS) and cardiovascular (CV) markets. The company was founded by Gregory Gubitz and Gilbert Godin on March 12, 2018 and is headquartered in Etobicoke, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
